Medicine & Life Sciences
Genome-Wide Association Study
100%
Triple Negative Breast Neoplasms
89%
Genes
84%
Neoadjuvant Therapy
78%
Squamous Cell Carcinoma
64%
Gene-Environment Interaction
61%
Pancreatic Neoplasms
59%
Single Nucleotide Polymorphism
53%
Gene Expression
49%
Exome
48%
Genotype
46%
Oropharyngeal Neoplasms
44%
Oropharynx
44%
Neoplasms
40%
Urinary Bladder Neoplasms
38%
Survival
37%
Deep Learning
37%
Mexican Americans
34%
Mutation
33%
Genome
30%
Phenotype
30%
National Heart, Lung, and Blood Institute (U.S.)
29%
Whole Exome Sequencing
29%
African Americans
27%
Tumor Burden
26%
fluciclovine F-18
25%
Radiotherapy
25%
Area Under Curve
24%
Whole Genome Sequencing
24%
Data Analysis
24%
Hepatocellular Carcinoma
24%
MicroRNAs
24%
Hispanic Americans
24%
Recurrence
23%
Liver Cirrhosis
22%
Gastrointestinal Microbiome
22%
Datasets
22%
Environmental Exposure
22%
Biomarkers
21%
Endothelial Protein C Receptor
21%
Lymphoma, Large B-Cell, Diffuse
21%
Genetic Crosses
21%
Vascular Diseases
21%
Endothelial Cells
20%
Acute Myeloid Leukemia
20%
DNA Methylation
19%
factor VIII, von Willebrand factor drug combination
19%
Carcinoma
19%
Sickle Cell Anemia
18%
Mathematics
Gene
36%
Mediation
29%
DNA-binding Protein
29%
Genomics
26%
Transcription Factor
26%
Gene Networks
26%
Mixture Model
23%
Cholesterol
20%
Adaptive Test
19%
Gene Expression
17%
Target
12%
Tumor
12%
Oncology
11%
False Discovery Rate
11%
High-dimensional
11%
Lipoproteins
10%
Data Integration
10%
Gene-environment Interaction
10%
Joint Model
10%
Coronary Heart Disease
10%
Bayesian Model Averaging
10%
Markov Random Field
10%
Mediator
10%
Risk Difference
9%
DNA Sequence
9%
Joint Modeling
9%
Diabetes
9%
Bayesian Modeling
9%
Gene Expression Data
8%
Cancer
8%
Landmarks
8%
Therapy
8%
Two-sample Test
8%
Modeling
8%
Model
8%
Genome
8%
Low Frequency
7%
Multivariate Models
7%
Rate Control
7%
Semiparametric Model
7%
Principal Components
7%
Bayesian inference
7%
Statistical test
7%
Parametric Model
7%
Regression Analysis
6%
Clinical Trials
6%
Gaussian Markov Random Field
6%
Main Effect
6%
Profile
5%